Spots Global Cancer Trial Database for hyperthermia treatment
Every month we try and update this database with for hyperthermia treatment cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Temperature-Sensitive Liposomal Doxorubicin and Hyperthermia in Treating Women With Locally Recurrent Breast Cancer | NCT00346229 | Breast Cancer | filgrastim pegfilgrastim lyso-thermosens... hyperthermia tr... | 18 Years - | Duke University | |
Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer | NCT00003135 | Breast Cancer Cervical Cancer Endometrial Can... Ovarian Cancer | fluorouracil pegylated lipos... hyperthermia tr... | 18 Years - | National Cancer Institute (NCI) | |
Paclitaxel and Hyperthermic Perfusion in Treating Patients With Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery | NCT00020007 | Lung Cancer Metastatic Canc... | isolated perfus... paclitaxel hyperthermia tr... | 18 Years - | National Cancer Institute (NCI) | |
Hyperthermia and High Dose Rate Radiation Therapy in Treating Patients With Recurrent Prostate Cancer After Radiation | NCT02899221 | Recurrent Prost... | High-Dose Rate ... Hyperthermia Tr... Laboratory Biom... | 18 Years - | Thomas Jefferson University | |
Hyperthermia and Olaparib in Treating Breast Cancer Patients With Chest Wall Recurrences | NCT03955640 | Metastatic Mali... Recurrent Breas... | Olaparib Hyperthermia Tr... Questionnaire A... Quality-of-Life... | 18 Years - 80 Years | Thomas Jefferson University | |
Systemic Chemotherapy With or Without Intraperitoneal Chemohyperthermia in Treating Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal Cancer | NCT00769405 | Colorectal Canc... Primary Periton... | fluorouracil leucovorin calc... oxaliplatin hyperthermia tr... | 18 Years - 70 Years | UNICANCER | |
Surgery, Chemotherapy, and Radiation Therapy in Treating Patients With Peritoneal Cancer | NCT00024271 | Malignant Mesot... | recombinant int... cisplatin doxorubicin hyd... gemcitabine hyd... mitomycin C conventional su... hyperthermia tr... radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
Cisplatin and Radiation Therapy With or Without Hyperthermia Therapy in Treating Patients With Cervical Cancer | NCT00085631 | Cervical Cancer | cisplatin hyperthermia tr... brachytherapy external beam r... | 18 Years - | Duke University | |
Temperature-Sensitive Liposomal Doxorubicin and Hyperthermia in Treating Women With Locally Recurrent Breast Cancer | NCT00346229 | Breast Cancer | filgrastim pegfilgrastim lyso-thermosens... hyperthermia tr... | 18 Years - | Duke University | |
Cisplatin, Metronomic Low-Dose Interferon Alfa, Gemcitabine, and Fever-Range Whole-Body Hyperthermia in Treating Patients With Inoperable or Metastatic Pancreatic Cancer | NCT00082862 | Pancreatic Canc... | recombinant int... cisplatin gemcitabine hyd... hyperthermia tr... | 18 Years - | National Cancer Institute (NCI) | |
Chemotherapy With or Without Isolated Hepatic Perfusion With Melphalan in Treating Patients With Colorectal Cancer That Has Spread to the Liver | NCT00020501 | Colorectal Canc... Metastatic Canc... | FOLFIRI regimen floxuridine fluorouracil irinotecan hydr... leucovorin calc... melphalan hyperthermia tr... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
Body Warming in Improving Blood Flow and Oxygen Delivery to Tumors in Patients With Cancer | NCT01896778 | Adult Liver Car... Breast Carcinom... Colon Carcinoma Kidney Neoplasm Lung Carcinoma Malignant Head ... Malignant Neopl... Melanoma Ovarian Neoplas... Soft Tissue Sar... | Hyperthermia Tr... Laboratory Biom... | 18 Years - | Roswell Park Cancer Institute | |
Whole Body Hyperthermia Combined With Chemotherapy in Treating Patients With Metastatic Breast, Ovarian, Endometrial, or Cervical Cancer | NCT00003135 | Breast Cancer Cervical Cancer Endometrial Can... Ovarian Cancer | fluorouracil pegylated lipos... hyperthermia tr... | 18 Years - | National Cancer Institute (NCI) | |
Hyperthermia and Olaparib in Treating Breast Cancer Patients With Chest Wall Recurrences | NCT03955640 | Metastatic Mali... Recurrent Breas... | Olaparib Hyperthermia Tr... Questionnaire A... Quality-of-Life... | 18 Years - 80 Years | Thomas Jefferson University | |
Liposomal Doxorubicin and Thermal Therapy in Treating Patients With Prostate Cancer | NCT00061867 | Prostate Cancer | pegylated lipos... hyperthermia tr... | 40 Years - | National Cancer Institute (NCI) | |
Chemotherapy With or Without Isolated Hepatic Perfusion With Melphalan in Treating Patients With Colorectal Cancer That Has Spread to the Liver | NCT00020501 | Colorectal Canc... Metastatic Canc... | FOLFIRI regimen floxuridine fluorouracil irinotecan hydr... leucovorin calc... melphalan hyperthermia tr... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
Cisplatin Combined With Radiation Therapy and Hyperthermia in Treating Patients With Stage II, Stage III, or Stage IV Cervical Cancer | NCT00008112 | Cervical Cancer | cisplatin hyperthermia tr... brachytherapy radiation thera... | 18 Years - | National Cancer Institute (NCI) | |
Liposomal Doxorubicin and Thermal Therapy in Treating Patients With Prostate Cancer | NCT00061867 | Prostate Cancer | pegylated lipos... hyperthermia tr... | 40 Years - | National Cancer Institute (NCI) | |
Hyperthermia and Olaparib in Treating Breast Cancer Patients With Chest Wall Recurrences | NCT03955640 | Metastatic Mali... Recurrent Breas... | Olaparib Hyperthermia Tr... Questionnaire A... Quality-of-Life... | 18 Years - 80 Years | Thomas Jefferson University | |
Combination Chemotherapy With or Without Whole-Body Hyperthermia in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer | NCT00045461 | Fallopian Tube ... Ovarian Cancer Primary Periton... | carboplatin ifosfamide hyperthermia tr... | 18 Years - 65 Years | National Cancer Institute (NCI) | |
Hyperthermia and Mitomycin C, Bacillus Calmette-Guerin, or Standard Therapy as Second-Line Therapy in Treating Patients With Recurrent Bladder Cancer | NCT01094964 | Bladder Cancer | BCG solution recombinant int... epirubicin hydr... mitomycin C laboratory biom... hyperthermia tr... quality-of-life... | 18 Years - | National Cancer Institute (NCI) | |
Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma | NCT00003052 | Sarcoma | doxorubicin hyd... etoposide ifosfamide conventional su... hyperthermia tr... radiation thera... | 18 Years - 70 Years | National Cancer Institute (NCI) | |
Melphalan and Whole-Body Hyperthermia in Treating Patients With Advanced Melanoma | NCT00002973 | Melanoma (Skin) | melphalan hyperthermia tr... | 16 Years - 120 Years | University of Wisconsin, Madison |